New studies are being done on COVID patients and microthrombi/pulmonary embolism. MEDPAGE Today published on April 8th that they are noting systemic clotting problems in patients with COVID-19, even with those patients on prophylactic anticoagulation. They have noticed that the D-dimer, that checks for clotting issues, has been linked to a greater odd of death with COVID-19 patients in Wuhan, China. Some are recommending Heparin drips for an anticoagulant since its anti-inflammatory effect would be preferable with the inflammation of COVID-19. The patient’s other presenting potential bleeding factors would need to be assessed. Although there is no data on this, that’s where we are with COVID-19.
April 8, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/85865
April 9, 2020 https://rebelem.com/covid-19-thrombosis-and-hemoglobin/
April 8, 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141630/
April 6, 2020 https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf
April 10, 2020 https://www.youtube.com/watch?v=o8aG63yigjA